The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation Syndrome
Abstract
Objective: Systemic juvenile idiopathic arthritis (JIA) is associated with high levels of interleukin‐6 (IL‐6) in the serum and synovial fluid, and impairment of natural killer (NK) cell function is often observed. This study was undertaken to evaluate a possible link between these 2 biologic findings and whether they may be associated with the development of macrophage activation syndrome, a condition frequently observed in systemic JIA. Methods: Splenocytes from wild‐type (WT) or IL‐6–transgenic (Tg) mice were evaluated for NK cell cytotoxicity using a 51 Cr‐release assay. Numbers of NK cells and expression of perforin, granzyme B, CD69, and CD107a were evaluated by flow cytometry. Human peripheral blood mononuclear cells (PBMCs) isolated from healthy donors were treated with IL‐6 and cultured in the presence or absence of tocilizumab (TCZ), an IL‐6 receptor blocker. Human polyclonal NK cells from healthy donor PBMCs were evaluated for cell cytotoxicity and expression of perforin, granzyme B, and CD107a. PBMCs harvested from patients with systemic JIA during periods of active or inactive disease were left untreated or treated with IL‐6 in combination with soluble IL‐6 receptor and analyzed for the expression of perforin and granzyme B. Results: Splenic NK cell cytotoxicity was reduced in IL‐6–Tg mice compared to WT mice. Levels of CD69 and CD107a showed no significant differences, whereas expression of perforin and granzyme B was impaired in NK cells from IL‐6–Tg mice. Exposure of human peripheral blood NK cells to IL‐6 led to reduced expression of perforin and granzyme B. Culturing human polyclonal NK cells in the presence of TCZ significantly increased cell cytotoxicity, and also increased expression of perforin and granzyme B. In patients with systemic JIA, a reduction in IL‐6 plasma levels during disease remission correlated with the rescue of perforin and granzyme B expression in NK cells from these patients. Conclusion: In both mice and humans, IL‐6 down‐modulated the cytotoxic activity of NK cells. This decrease was associated with reduced perforin and granzyme B levels in the absence of altered granule exocytosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 1×
“It is activated upon stimulation with IL-6 and participates in endogenous negative feedback to limit cytokine signaling (42).”
BackgroundIL-6 as a keystone cytokine in health and disease
Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511
CD107a as a functional marker for the identification of natural killer cell activity
Alter, G., Malenfant, J. M., & Altfeld, M. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2004.08.008 · Cited by 1,410
Controlling Natural Killer Cell Responses: Integration of Signals for Activation and Inhibition
Long, E. O., Sik Kim, H., Liu, D., Peterson, M. E., & Rajagopalan, S. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075005 · Cited by 1,217
Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., Woo, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112802 · Cited by 763
Self-citationNatural killer cells and dendritic cells: rendezvous in abused tissues
Moretta, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri956 · Cited by 704
Familial and Acquired Hemophagocytic Lymphohistiocytosis
Janka, G. E. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-041610-134208 · Cited by 549
De Benedetti, F., Alonzi, T., Moretta, A., Lazzaro, D., Costa, P., Poli, V, Martini, A., Ciliberto, G., & Fattori, E. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119207 · Cited by 529 · cited 2×
“Generation of the IL-6–Tg mice has been described in detail previously (17,18).”
BackgroundMethodMinoia, F., Davì, S., Horne, A., Demirkaya, E., Bovis, F., Li, C., Lehmberg, K., Weitzman, S., Insalaco, A., Wouters, C., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38802 · Cited by 429
Repeated TLR9 stimulation results in macrophage activation syndrome–like disease in mice
Behrens, E. M., Canna, S. W., Slade, K., Rao, S., Kreiger, P. A., Paessler, M., Kambayashi, T., & Koretzky, G. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43157 · Cited by 392
Ravelli, A., Grom, A. A., Behrens, E. M., & Cron, R. Q. (2012) · Genes & Immunity · doi:10.1038/gene.2012.3 · Cited by 386
Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
Mellins, E. D., Macaubas, C., & Grom, A. A. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.68 · Cited by 330
Wang, R., Jaw, J. J., Stutzman, N. C., Zou, Z., & Sun, P. D. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0611308 · Cited by 301
Grom, A. A., Villanueva, J., Lee, S., Goldmuntz, E. A., Passo, M. H., & Filipovich, A. (2003) · The Journal of Pediatrics · doi:10.1067/mpd.2003.110 · Cited by 284
Cohney, S. J., Sanden, D., Cacalano, N. A., Yoshimura, A., Mui, A., Migone, T. S., & Johnston, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4980 · Cited by 265
Shimizu, M., Yokoyama, T., Yamada, K., Kaneda, H., Wada, H., Wada, T., Toma, T., Ohta, K., Kasahara, Y., & Yachie, A. (2010) · Rheumatology · doi:10.1093/rheumatology/keq133 · Cited by 255
Villanueva, J., Lee, S., Giannini, E. H., Graham, T. B., Passo, M. H., Filipovich, A., & Grom, A. A. (2004) · Arthritis Res Ther · doi:10.1186/ar1453 · Cited by 243
Hyodo, Y., Matsui, K., Hayashi, N., Tsutsui, H., Kashiwamura, S.-I., Yamauchi, H., Hiroishi, K., Takeda, K., Tagawa, Y.-I., Iwakura, Y., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1662 · Cited by 233
Vastert, S. J., van Wijk, R., D’Urbano, L. E., de Vooght, K. M. K., de Jager, W., Ravelli, A., Magni-Manzoni, S., Insalaco, A., Cortis, E., van Solinge, W. W., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/kep418 · Cited by 231
Self-citationHuman NK cell lytic granules and regulation of their exocytosis
Krzewski, K., & Coligan, J. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00335 · Cited by 229
IL-6 Promotes NK Cell Production of IL-17 during Toxoplasmosis
Passos, S. T., Silver, J. S., O’Hara, A. C., Sehy, D., Stumhofer, J. S., & Hunter, C. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901843 · Cited by 223
Molecular Mechanisms of Natural Killer Cell Activation
Bryceson, Y. T., Chiang, S. C. C., Darmanin, S., Fauriat, C., Schlums, H., Theorell, J., & Wood, S. M. (2011) · Journal of Innate Immunity · doi:10.1159/000325265 · Cited by 221
Kashii, Y., Giorda, R., Herberman, R. B., Whiteside, T. L., & Vujanovic, N. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.10.5358 · Cited by 220
Grom, A. A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20198 · Cited by 208
Kaufman, K. M., Linghu, B., Szustakowski, J. D., Husami, A., Yang, F., Zhang, K., Filipovich, A. H., Fall, N., Harley, J. B., Nirmala, N. R., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38793 · Cited by 207
Zhang, K., Biroschak, J., Glass, D. N., Thompson, S. D., Finkel, T., Passo, M. H., Binstadt, B. A., Filipovich, A., & Grom, A. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23734 · Cited by 182
de Jager, W., Vastert, S. J., Beekman, J. M., Wulffraat, N. M., Kuis, W., Coffer, P. J., & Prakken, B. J. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24750 · Cited by 164
Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?
Benedetti, F. D., & Martini, A. (1998) · PubMed · Cited by 162
IFN-beta2/IL-6 augments the activity of human natural killer cells.
Luger, T., Krutmann, J., Kirnbauer, R., Urbanski, A., Schwarz, T., Klappacher, G., Köck, A., Micksche, M., Malejczyk, J., Schauer, E., et al. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1206 · Cited by 150
Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?
Grom, A. A. (2003) · Current Opinion in Rheumatology · doi:10.1097/00002281-200309000-00011 · Cited by 148
NK cell functions restrain T cell responses during viral infections
Su, H. C., Nguyen, K. B., Salazar‐Mather, T. P., Ruzek, M. C., Dalod, M., & Biron, C. A. (2001) · European Journal of Immunology · Cited by 142
Identification of Shp-2 as a Stat5A Phosphatase
Chen, Y., Wen, R., Yang, S., Schuman, J., Zhang, E. E., Yi, T., Feng, G., & Wang, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210572200 · Cited by 132
Review of haemophagocytic lymphohistiocytosis
Freeman, H. R., & Ramanan, A. V. (2010) · Archives of Disease in Childhood · doi:10.1136/adc.2009.176610 · Cited by 132
The Interactions of Multiple Cytokines Control NK Cell Maturation
Brady, J., Carotta, S., Thong, R. P. L., Chan, C. J., Hayakawa, Y., Smyth, M. J., & Nutt, S. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903354 · Cited by 130 · cited 1×
“In this respect, while treatment with IL-18 alone increases NK cell activity, prolonged exposure to combinations of IL-18 and IL-15 markedly decreases NK cell cytotoxic activity (38).”
BackgroundStrippoli, R., Carvello, F., Scianaro, R., Pasquale, L. D., Vivarelli, M., Petrini, S., Bracci‐Laudiero, L., & Benedetti, F. D. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33496 · Cited by 123
Self-citationFox, A., Hoa, L. N. M., Horby, P., van Doorn, H. R., Trung, N. V., Ha, N. H., Trung, N., Phu, V. D., Ha, N. M., Ngoc, D. N. T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031535 · Cited by 118
Hazen, M. M., Woodward, A., Hofmann, I., Degar, B. A., Grom, A. A., Filipovich, A. H., & Binstadt, B. A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23199 · Cited by 112
Zhang, J., Scordi, I., Smyth, M. J., & Lichtenheld, M. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.9.1297 · Cited by 112
Inflammatory arthritis can be reined in by CpG-induced DC–NK cell cross talk
Wu, H.-J. J., Sawaya, H., Binstadt, B. A., Brickelmaier, M., Blasius, A. L., Gorelik, L., Mahmood, U., Weissleder, R., Carulli, J. P., Benoist, C. O., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070285 · Cited by 97
Tanner, J. E., & Tosato, G. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115283 · Cited by 89
Reaching the Threshold: A Multilayer Pathogenesis of Macrophage Activation Syndrome
Strippoli, R., Caiello, I., & Benedetti, F. D. (2013) · The Journal of Rheumatology · doi:10.3899/jrheum.121233 · Cited by 87
Self-citationCifaldi, L., Monaco, E. L., Forloni, M., Giorda, E., Lorenzi, S., Petrini, S., Tremante, E., Pende, D., Locatelli, F., Giacomini, P., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3326 · Cited by 85
Self-citationCaiello, I., Minnone, G., Holzinger, D., Vogl, T., Prencipe, G., Manzo, A., Benedetti, F. D., & Strippoli, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107886 · Cited by 80
Self-citationThe human perforin gene is a direct target of STAT4 activated by IL-12 in NK cells
Yamamoto, K., Shibata, F., Miyasaka, N., & Miura, O. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02378-1 · Cited by 64
Interleukin-6 (IL-6) expression and natural killer (NK) cell dysfunction and anergy in heart failure
Vredevoe, D. L., Widawski, M., Fonarow, G. C., Hamilton, M. A., Martı́nez-Maza, O., & Gage, J. R. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.054 · Cited by 61
Gismondi, A., Jacobelli, J., Strippoli, R., Mainiero, F., Soriani, A., Cifaldi, L., Piccoli, M., Frati, L., & Santoni, A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3065 · Cited by 60
Self-citationScheid, C., Young, R., McDermott, R. H., Fitzsimmons, L., Scarffe, J. H., & Stern, P. L. (1994) · Cancer Immunology Immunotherapy · doi:10.1007/bf01526207 · Cited by 52
Guo, X., Chen, Y., Li, X., et al. (2011) · Virology Journal · doi:10.1186/1743-422x-8-215 · Cited by 25
Cited by
Shimabukuro-Vornhagen, A., Gödel, P., Subklewe, M., Stemmler, H. J., Schlößer, H. A., Schlaak, M., Kochanek, M., Böll, B., & von Bergwelt-Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,656
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Natural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Wang, J., Jiang, M., Chen, X., & Montaner, L. J. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3covr0520-272r · Cited by 741
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Tanaka, T., Narazaki, M., & Kishimoto, T. (2016) · Immunotherapy · doi:10.2217/imt-2016-0020 · Cited by 708
Metadata
- Authors
- Cifaldi, L., Prencipe, G., Caiello, I., Bracaglia, C., Locatelli, F., De Benedetti, F., & Strippoli, R.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2015-10-28
- Volume
- 67
- Issue
- 11
- Pages
- 3037-3046
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W1867422291
- Cited by
- 267
- References
- 49
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.